Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Shares Issued (2022 - 2025)

Coya Therapeutics (COYA) has disclosed Shares Issued for 4 consecutive years, with $19137.0 as the latest value for Q3 2025.

  • Quarterly Shares Issued rose 100.55% to $19137.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $38274.0 through Dec 2025, down 98.21% year-over-year, with the annual reading at $38274.0 for FY2025, 98.21% down from the prior year.
  • Shares Issued hit $19137.0 in Q3 2025 for Coya Therapeutics, roughly flat from $19137.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $14.3 million in Q1 2023 to a low of -$3.5 million in Q3 2024.
  • Historically, Shares Issued has averaged $2.1 million across 4 years, with a median of $325279.0 in 2024.
  • Biggest five-year swings in Shares Issued: surged 9019084.18% in 2023 and later crashed 98.59% in 2025.
  • Year by year, Shares Issued stood at $158.0 in 2022, then soared by 9019084.18% to $14.3 million in 2023, then crashed by 95.57% to $631421.0 in 2024, then tumbled by 96.97% to $19137.0 in 2025.
  • Business Quant data shows Shares Issued for COYA at $19137.0 in Q3 2025, $19137.0 in Q1 2025, and $631421.0 in Q4 2024.